✦ LIBER ✦

Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial

✍ Scribed by Coppola, R; Beomonte Zobel, B; Trodella, L; Tonini, G; Vincenzi, B; Santini, D; Rabitti, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a Phase II Trial of Cetuximab

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

Phase II Study of Irinotecan and Cetuxim

✍ Benedito A. Carneiro; Ramesh K. Ramanathan; Marwan G. Fakih; Smitha S. Krishnamu 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 359 KB

Biweekly cetuximab and irinotecan in adv

✍ Martín-Martorell, P; Roselló, S; Rodríguez-Braun, E; Chirivella, I; Bosch, A; Ce 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase II randomised trial of raltitrexed

✍ Feliu, J; Castañón, C; Salud, A; Mel, J R; Escudero, P; Pelegrín, A; López-Gómez 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

1086 Cetuximab in a randomized phase II

✍ Van Cutsem, E.; Gascón Vilaplana, P.; Seitz, J.F.; Van Laethem, J.L.; Grossi, F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB